Rittmaster R. Evaluation and treatment of hirsutism. Infert Reprod Med Clin North Am 1991,2:511–545.
113.
Barth JH, Cherry CA, Wojnarowska F, et al. Spironolactone is an effective and well tolerated systemic andiandrogen therapy for hirsute women. J Clin Endocrinol Metab 1989;68:966–970.
114.
Pittaway DE, Maxson WS, Wentz AC. Spironolactone in combination drug therapy for unresponsive hirsutism. Fertil Steril 1985;43:878–882.
115.
Lobo RA, Shoupe D, Serafini P, et al. The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertil Steril 1985;43:200–205.
116. Calaf-Alsina J, Rodriguez-Espinosa J, Cabero-Roura A, et al. Effects of a cyproterone-containing oral contraceptive on hormonal levels in polycystic ovarian disease. Obstet Gynecol 1987;69:255– 258.
117. Helfer EL, Miller JL, Rose LI. Side-effects of spironolactone therapy in the hirsute woman. J Clin Endocrinol Metab 1988;66: 208–211.
118.
Miller JA, Jacobs HS. Treatment of hirsutism and acne with cyproterone acetate. Clin Endocrinol Metab 1986;15:373–389.
119.
Mowszowicz I, Wright F, Vincens M, et al. Androgen metabolism in hirsute patients treated with cyproterone acetate. J Steroid Biochem 1984;20:757–761.
120.
Girard J, Baumann JB, Buhler U, et al. Cyproteroneacetate and ACTH adrenal function. J Clin Endocrinol Metab 1978;47:581– 586.
121.
Marcondes JA, Minnani SL, Luthold WW, et al. Treatment of hirsutism in women with ﬂutamide. Fertil Steril 1992;57:543–547.
122.
Ciotta L, Cianci A, Marletta E, et al. Treatment of hirsutism with ﬂutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients. Fertil Steril 1994;62:1129–1135.
123.
Cusan L, Dupont A, Belanger A, et al. Treatment of hirsutism with the pure antiandrogen ﬂutamide. J Am Acad Dermatol 1990;23(Pt 1):462–469.
124.
Ibanez L, De Zegher F. Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third-to fourth-generation OC reduces body adiposity. Hum Reprod 2004;19:1725–1727.
125.